FountainVest, Primavera invest $557m in China pharmacy chain
FountainVest Partners and Primavera Capital have paid $557 million for a 24.78% stake in Chinese pharmacy chain Laobaixing. It will provide a full exit for EQT Partners.
The two investors will each take approximately 12.4% shares via FountainVest China Capital Partners Fund III and Primavera Capital Fund III, according to a statement. EQT Partners became the second-largest...
More on Greater China
Latest News
China cancer test kit provider gets $30m Series E
New Horizon Health, a China-based manufacturer of cancer testing kits for use at home, has raised $30 million in a Series E round of funding led by Rock Springs Capital.
China's Yingke PE raises $286m
Shanghai-based Yingke Private Equity has closed its latest renminbi-denominated fund with commitments of RMB2 billion ($286 million), primarily from insurers and other financial institutions.
Google commits $10b for India digitization effort
Google will launch a INR750 billion ($10 billion) fund to make equity, operational, infrastructure and ecosystem investments that seek to increase the pace of digitization in India.
Large-cap vehicles support PE fundraising revival in second quarter
Asia private equity fundraising rebounded from a seven-year low in the first quarter of the year to reach $24 billion for April through June, but commitments were concentrated on a handful of managers.